Growth Monitoring in Preterm Infants: Fenton Charts, Corrected Age, and Nutritional Optimization

Preterm infants require fundamentally different growth assessment and nutritional management compared to term-born children. Standard growth charts are inappropriate; chronologic age does not reflect developmental maturity; and nutritional requirements differ substantially. The clinical importance is underscored by the significant impact of early growth optimization on long-term neurodevelopmental outcomes, with the mean IQ of very preterm children 11–12 points lower than term-born infants, increasing to 15–20 points for those born at less than 26 weeks' gestation.

Fenton Growth Charts: The 2025 Update

The Fenton third-generation preterm growth charts (2025) represent a significant update based on a systematic review and meta-analysis of 4.8 million births from 15 countries, including 174,184 infants born at less than 30 weeks' gestation. Key improvements include:

• Exclusion of infants with abnormal fetal growth: Unlike previous versions, the 2025 charts are derived from preterm infants without intrauterine growth restriction, providing a true growth standard rather than a reference that includes pathologic growth patterns.
• Improved growth velocity consistency: The new charts demonstrate more uniform slopes across percentiles with closer alignment to fetal ultrasound estimates.
• Rescaled x-axis: The charts now use exact gestational age (weeks and days) rather than completed weeks, improving precision for growth monitoring.

The AAP recommends use of the Fenton Preterm Growth Chart until 50 weeks postmenstrual age, after which the percentiles match those of the WHO growth standards. Plot measurements using postmenstrual age (PMA) rather than corrected age during hospitalization. A 30-week gestation infant at 34 weeks PMA is plotted at 34 weeks, revealing whether the infant tracks the expected growth curve or deviates from expected trajectory.

Fenton vs. INTERGROWTH-21st

A 2026 comparison study found that growth chart selection substantially affects how preterm infants are classified:

• INTERGROWTH-21st applies stricter static thresholds, classifying more infants as small for gestational age at birth (20% vs. 13%) and with low head circumference (12% vs. 8%)
• Fenton identifies more dynamic declines over time (≥1 or ≥2 z-score declines)
• Both charts underestimated extrauterine growth restriction prevalence compared with WHO standards (63%)

Importantly, poor neonatal growth categorized using fetal references (Fenton, Olsen) showed stronger associations with long-term neurodevelopment than poor growth categorized using INTERGROWTH-21st standards. Poor weight gain using the Fenton reference was associated with 18-month Mental Developmental Index <85 (aOR 1.6, 95% CI 1.1–2.4), whereas poor weight gain by INTERGROWTH-21st was not (aOR 1.0, 95% CI 0.6–1.7).

Corrected Age: Duration and Application

The AAP recommends using corrected age for all growth and developmental assessments until 24 months of corrected age. After 50 weeks postmenstrual age, transition to WHO growth standards plotted using corrected age.

A 2025 study of 1,416 extremely and very preterm children demonstrated that age correction is required through at least 36 months of corrected age for accurate growth assessment. Using chronologic age instead of corrected age resulted in:

• Weight z-scores up to 5.2 z-scores lower than corrected age-based scores at term
• Up to 72.9% of children misclassified as stunted and 89.8% misdiagnosed as underweight at term
• Persistent misclassification through 36 months of age

Corrected Age Calculation

Corrected age = Chronologic age − (40 weeks − Gestational age at birth)

For example, a 6-month-old infant born at 28 weeks gestation has a corrected age of approximately 3 months (6 months − 3 months prematurity = 3 months corrected age).

Growth Velocity Targets

Growth velocity recommendations must be interpreted in the context of postmenstrual age, as human growth is not constant through gestation and early infancy.

Weight Gain

• 15–20 g/kg/day is a reasonable goal for infants 23–36 weeks PMA (calculated using average or exponential methods)
• The frequently quoted "15 g/kg/day" only fits current growth references for limited time periods — rates are higher before 34 weeks and lower after
• Weight gain <10 g/kg/day indicates inadequate nutritional support
• Weight gain >25 g/kg/day raises concern for fluid overload

Length Velocity

• 1 cm/week fits growth references for approximately 37–40 weeks PMA
• Suboptimal length velocity is associated with neurodevelopmental problems

Head Circumference

• 1 cm/week fits growth references for approximately 23–30 weeks PMA
• Inadequate head growth is associated with impaired neurodevelopment and poor cognitive outcomes

Post-Discharge Growth Velocity

Nutritional Requirements

The AAP recommends the following nutritional targets for preterm infants:

Protein:

• 3.5–4.5 g/kg/day of enteral protein for preterm infants
• Infants with birth weight <1000 g require approximately 4–4.5 g/kg/day
• Infants with birth weight 1000–1500 g require approximately 3.5–4 g/kg/day
• Protein intake between 3–4 g/kg/day promotes weight gain and nitrogen accretion

Energy:

• 110–135 kcal/kg/day for hospitalized VLBW infants
• 100–120 kcal/kg/day post-discharge for weight gain of at least 20–30 g/day

When managing total parenteral nutrition, use the GIR Calculator to optimize glucose infusion rates and prevent hyperglycemia, and the Neonatal TPN Calculator to dial in patient-specific macronutrient needs.

Breast Milk Fortification

Human milk is the preferred source of nutrition for all preterm infants, providing protection against sepsis, necrotizing enterocolitis (NEC), and improved neurodevelopmental outcomes. However, unfortified human milk provides only approximately 67 kcal/100 mL and 1.1 g/100 mL of protein, which is insufficient to meet the nutritional needs of VLBW infants.

Fortification Evidence

• Multi-nutrient fortification increases in-hospital weight gain by 1.76 g/kg/day (95% CI 1.30–2.22)
• Length gain increases by 0.11 cm/week (95% CI 0.08–0.15)
• Head circumference gain increases by 0.06 cm/week (95% CI 0.03–0.08)
• Low-certainty evidence suggests no significant increase in NEC risk (RR 1.37, 95% CI 0.72–2.63)

Fortification Approaches

1. Standard (fixed) fortification: Adding fortifier at a fixed dose to achieve approximately 80 kcal/100 mL and 2 g protein/100 mL
2. Adjustable fortification: Using blood urea nitrogen as a surrogate for protein nutriture to modify fortification dosage
3. Targeted (individualized) fortification: Based on periodic human milk analysis using point-of-care milk analyzers; an RCT showed improved growth with individualized compared with standardized fortification

Use the Feeding Fortification Calculator to determine appropriate fortification as feeding volumes are advanced.

Timing of Fortification

• Several recent RCTs of fortification at feeding volumes <80 mL/kg/day showed no associations with feeding intolerance or NEC
• A 2023 RCT showed improved linear growth among preterm infants <28 weeks who received fortification on day 2 compared with day 14, suggesting benefit from very early fortification
• A 2025 RCT in very preterm infants found early fortification (days 4–7) led to higher weight (+131 g), higher FFM (+103 g), and higher length (+0.9 cm) compared with delayed fortification (days 10–14)

Mother's Own Milk vs. Donor Milk

• Mother's own milk (MOM) of preterm infants has higher protein content than term milk until about 10–12 weeks after birth
• Pasteurized donor human milk (PDHM) has significantly lower protein, sodium, chloride, potassium, and zinc content compared with preterm MOM
• Preterm infants supplemented with PDHM may have increased risk of slower growth even with fortification
• MOM is nutritionally and biologically superior to PDHM, reinforcing the importance of supporting mothers in maximal lactation
• PDHM is recommended when MOM is not available, as it reduces NEC risk compared with formula, but does not confer the additional health benefits of MOM such as reduction in late-onset sepsis and improved neurodevelopment

Neurodevelopmental Outcomes and Growth

Early-life growth has significant implications for long-term neurodevelopment:

Head Circumference

• Inadequate head growth is associated with impaired neurodevelopment and poor cognitive outcomes
• A 1-unit increase in HC z-score from birth to 18–24 months corrected age is associated with lower odds of significant cognitive/motor impairment (OR 0.81, 95% CI 0.75–0.88)

Weight Gain

• A 1 g/day increase in weight from discharge to 18–24 months corrected age is associated with lower odds of significant cognitive/motor impairment (OR 0.87, 95% CI 0.83–0.91)

Growth Restriction

• Preterm infants who are SGA without catch-up growth have unfavorable neurodevelopmental outcomes (IQ β −6.5, 95% CI −9.8 to −3.2)
• SGA infants with catch-up growth are comparable to adequately grown infants
• Achieving adequate early-life growth may be crucial for improving neurodevelopmental outcomes

Post-Discharge Management

Growth Expectations

• Healthy preterm infants typically achieve growth catch-up by 12–24 months corrected age
• Premature infants who are SGA at birth demonstrate slower catch-up growth and lower bone mass accumulation compared with those who are AGA
• Failure to achieve growth catch-up by 36 months is associated with suboptimal neurodevelopmental outcomes

Nutritional Guidance

• Continue fortified breast milk or nutrient-enriched formula until catch-up growth is achieved
• Once catch-up growth is achieved, discontinue fortification to prevent hypervitaminosis, obesity, and hypertension
• Post-discharge caloric needs: 100–120 kcal/kg/day for weight gain of at least 20–30 g/day
• Dietary advancement should coincide with neurodevelopmental milestones rather than a specific chronologic age

Follow-Up Schedule

• Schedule early post-discharge follow-up within 1–2 weeks
• Ensure families and primary care providers understand corrected age application
• Continue using corrected age for all assessments through 24–36 months
• Standardized developmental screening, adjusted for corrected age, is particularly crucial in infants with higher risk of developmental delays

Key Clinical Priorities

1. Use the 2025 Fenton charts for preterm infants until 50 weeks PMA, then transition to WHO standards with corrected age.
2. Apply corrected age through at least 24–36 months — using chronologic age causes substantial misclassification of growth status.
3. Target growth velocities are age-dependent: 15–20 g/kg/day weight gain is appropriate for 23–36 weeks PMA but not beyond.
4. Protein requirements are high: 3.5–4.5 g/kg/day for preterm infants, with higher requirements for ELBW infants.
5. Fortify human milk for all VLBW infants — unfortified breast milk cannot meet nutritional needs.
6. Prioritize mother's own milk over donor milk when possible due to superior nutritional and immunologic properties.
7. Monitor head circumference closely — it is a critical indicator of brain growth and neurodevelopment.
8. Recognize that growth chart selection matters: Fenton charts show stronger associations with neurodevelopmental outcomes than INTERGROWTH-21st.
9. Support catch-up growth in SGA infants — those without catch-up have significantly worse neurodevelopmental outcomes.
10. Discontinue fortification once catch-up growth is achieved to prevent overnutrition complications.

Optimal preterm infant growth management requires specialized knowledge: appropriate application of Fenton growth charts, accurate corrected age calculation, individualized fortification strategies, and recognition of the critical link between early growth and long-term neurodevelopmental outcomes.

References

1. Inder TE, Volpe JJ, Anderson PJ. Defining the Neurologic Consequences of Preterm Birth. N Engl J Med. 2023;389(5):441-453.
2. Fenton TR, Elmrayed S, Alshaikh BN. Fenton Third-Generation Growth Charts of Preterm Infants Without Abnormal Fetal Growth: A Systematic Review and Meta-Analysis. Paediatr Perinat Epidemiol. 2025.
3. Fenton TR, Elmrayed S, Alshaikh BN. Fenton Third-Generation Growth Charts of Preterm Infants Without Abnormal Fetal Growth: A Systematic Review and Meta-Analysis. Paediatr Perinat Epidemiol. 2025;39(6):543-555.
4. Bybel M, Delaney CA, Coble K. Outpatient Care of the Premature Infant. Am Fam Physician. 2025;112(2):153-161.
5. Merino-Hernández A, Rodríguez-Corrales E, Ramos-Navarro C, et al. Fenton vs INTERGROWTH-21st Charts in Preterm Infants < 32 Weeks: Impact of Chart Selection on Growth Classification. Eur J Pediatr. 2026;185(2):114.
6. Cordova EG, Cherkerzian S, Bell K, et al. Association of Poor Postnatal Growth With Neurodevelopmental Impairment in Infancy and Childhood: Comparing the Fetus and the Healthy Preterm Infant References. J Pediatr. 2020;225:37-43.e5.
7. Elmrayed S, Dai S, Lodha A, Kumar M, Fenton TR. Preterm Growth Assessment: The Latest Findings on Age Correction. J Perinatol. 2025;45(5):607-615.
8. Fenton TR, Anderson D, Groh-Wargo S, et al. An Attempt to Standardize the Calculation of Growth Velocity of Preterm Infants — Evaluation of Practical Bedside Methods. J Pediatr. 2018;196:77-83.
9. Fabrizio V, Trzaski JM, Brownell EA, et al. Individualized Versus Standard Diet Fortification for Growth and Development in Preterm Infants Receiving Human Milk. Cochrane Database Syst Rev. 2020;11:CD013465.
10. Fenton TR, Al-Wassia H, Premji SS, Sauve RS. Higher Versus Lower Protein Intake in Formula-Fed Low Birth Weight Infants. Cochrane Database Syst Rev. 2020;6:CD003959.
11. Abiramalatha T, Thomas N, Thanigainathan S. High Versus Standard Volume Enteral Feeds to Promote Growth in Preterm or Low Birth Weight Infants. Cochrane Database Syst Rev. 2021;3:CD012413.
12. Meek JY, Noble L. Technical Report: Breastfeeding and the Use of Human Milk. Pediatrics. 2022;150(1):e2022057989.
13. Thanigainathan S, Abiramalatha T. Early Fortification of Human Milk Versus Late Fortification to Promote Growth in Preterm Infants. Cochrane Database Syst Rev. 2020;7:CD013392.
14. Brown JV, Lin L, Embleton ND, Harding JE, McGuire W. Multi-Nutrient Fortification of Human Milk for Preterm Infants. Cochrane Database Syst Rev. 2020;6:CD000343.
15. Parker MG, Stellwagen L, Miller ER, et al. Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant: Clinical Report. Pediatrics. 2026;157(2):e2025073625.
16. Salas AA, Gunawan E, Nguyen K, et al. Early Human Milk Fortification in Infants Born Extremely Preterm: A Randomized Trial. Pediatrics. 2023;152(3):e2023061603.
17. Salas AA, Gunawan E, Jeffcoat S, Nguyen K. Early Full Enteral Nutrition With Fortified Milk in Very Preterm Infants: A Randomized Clinical Trial. Am J Clin Nutr. 2025;121(5):1117-1123.
18. Gates A, Hair AB, Salas AA, Thompson AB, Stansfield BK. Nutrient Composition of Donor Human Milk and Comparisons to Preterm Human Milk. J Nutr. 2023;153(9):2622-2630.
19. Ruys CA, Hollanders JJ, Bröring T, et al. Early-Life Growth of Preterm Infants and Its Impact on Neurodevelopment. Pediatr Res. 2019;85(3):283-292.
20. Bando N, Fenton TR, Yang J, et al. Association of Postnatal Growth Changes and Neurodevelopmental Outcomes in Preterm Neonates of <29 Weeks' Gestation. J Pediatr. 2023;256:63-69.e2.
21. Davis BE, Leppert MO, German K, Lehmann CU, Adams-Chapman I. Primary Care Framework to Monitor Preterm Infants for Neurodevelopmental Outcomes in Early Childhood. Pediatrics. 2023;152(1):e2023062511.